Platelets compensate for poor thrombin generation in type 3 von Willebrand disease

References

• Ruggeri ZM. von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost 2003;1(7):1335–1342.
   PubMed Web of Science ®Google Scholar
• Siljander P, Carpen O, Lassila R. Platelet-derived microparticles associate with fibrin during thrombosis. Blood 1996;87(11):4651–4663.
   PubMed Web of Science ®Google Scholar
• Beguin S, Kumar R, Keularts I, Seligsohn U, Coller BS, Hemker HC. Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor. Blood 1999;93(2):564–570.
   PubMed Web of Science ®Google Scholar
• Ruggeri ZM, Orje JN, Habermann R, Federici AB, Reininger AJ. Activation-independent platelet adhesion and aggregation under elevated shear stress. Blood 2006;108(6):1903–1910. doi:10.1182/blood-2006-04-011551.
   PubMed Web of Science ®Google Scholar
• Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmerg L, Ingerslev J, Lee CA, Lillicrap D, Mannucci PM, et al. Working party on von Willebrand disease classification. Update on the pathophysiologyand classification of von Willebrand disease: a report of the subcommittee on von Willebrand factor. J Thromb Haemost 2006;4(10):2103–2114. doi:10.1111/j.1538-7836.2006.02117.x.
   PubMed Web of Science ®Google Scholar
• Eikenboom JC. Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology. Best Pract Res Clin Haematol 2001;14(2):365–379. doi:10.1053/beha.2001.0139.
   PubMed Web of Science ®Google Scholar
• Sood SL, Cuker A, Wang C, Metjian AD, Chiang EY, Soucie JM, Konkle, B A., HTCN Study Investigators. Similarity in joint function limitation in Type 3 von Willebrand’s disease and moderate haemophilia A. Haemophilia 2013;19(4):595–601. doi:10.1111/hae.12119.
   PubMed Web of Science ®Google Scholar
• Sanders YV, Groeneveld D, Meijer K, Fijnvandraat K, Cnossen MH, van der Bom JG, Coppens, M, de Meris J., Laros-van Gorkom Britta AP, Mauser-Bunschoten EP, Leebeek Frank WG, Eikenboom J. WiN study group.von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease. Blood 2015;125(19):3006–3013. doi:10.1182/blood-2014-09-603241.
   PubMed Web of Science ®Google Scholar
• Jokela V, Lassila R, Szanto T, Joutsi-Korhonen L, Armstrong E, Oyen F, Schneppenheim, S, Schneppenheim, R Phenotypic and genotypic characterization of 10 Finnish patients with von Willebrand disease type 3: discovery of two main mutations. Haemophilia 2013;19(6):e344–e348. doi:10.1111/hae.12225.
   PubMed Web of Science ®Google Scholar
• Berntorp E, Petrini P. Long-term prophylaxis in von Willebrand disease. Blood Coagul Fibrinolysis 2005;16(Suppl 1):S23–S26.
   PubMedGoogle Scholar
• Abshire TC, Federici AB, Alvárez MT, Bowen J, Carcao MD, Cox Gill J, Key NS, Kouides, PA, Kurnik K, Lail AE, Leebeek FWG, Makris, M, Mannucci PM, Winikoff R, Berntorp E. Prophylaxis in severe forms of von Willebrand’s disease: results from the von Willebrand disease prophylaxis network (VWD PN). Haemophilia 2013;19(1):76–81. doi:10.1111/j.1365-2516.2012.02916.x.
   PubMed Web of Science ®Google Scholar
• Federici AB. Current and emerging approaches for assessing von Willebrand disease in 2016. Int J Lab Hematol 2016;38(Suppl 1):41–49. doi:10.1111/ijlh.12540.
   PubMedGoogle Scholar
• Szántó T, Schlammadinger A, Salles I, Pareyn I, Vauterin S, Hársfalvi J, Vanden Bulcke A-M, Deckmyn H, Vanhoorelbeke K. Type 2B von Willebrand disease in seven individuals from three different families: phenotypic and genotypic characterization. Thromb Haemost 2007;98(1):251–254.
   PubMed Web of Science ®Google Scholar
• Casonato A, Cattini MG, Daidone V, Pontara E, Bertomoro A, Prandoni P, Cox D. Diagnostic value of measuring platelet von willebrand factor in von Willebrand disease. PLoS One 2016;11:e0161310. doi:10.1371/journal.pone.0161310.
   PubMed Web of Science ®Google Scholar
• Kremers RM, Peters TC, Wagenvoord RJ, Hemker HC. The balance of pro- and anticoagulant processes underlying thrombin generation. J Thromb Haemost 2015;13(3):437–447. doi:10.1111/jth.12813.
   PubMed Web of Science ®Google Scholar
• Hemker HC, Al Dieri R, De Smedt E, Beguin S. Thrombin generation, a function test of the haemostatic thrombotic system. Thromb Haemost 2006;96(5):553–561. doi:10.1160/TH06-07-0408.
   PubMed Web of Science ®Google Scholar
• Rugeri L, Beguin S, Hemker C, Bordet J-C., Fleury R, Chatard B Negrier, C., Dargaud, Y. Thrombin-generating capacity in patients with von Willebrand’s disease. Haematologica 2007;92(12):1639–1646. doi:10.3324/haematol.11460.
   PubMed Web of Science ®Google Scholar
• Rodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P, Neunert C, Lillicrap D. ISTH/SSC Joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleedingscore for inherited bleeding disorders. J Thromb Haemost 2010;8(9):2063–2065. doi:10.1111/j.1538-7836.2010.03975.x.
   PubMed Web of Science ®Google Scholar
• Patzke, J, Budde U, Huber A, Méndez A, Muth H, Obser T, Peerschke, E., Wilkens, M., Schneppenheim, R. Performance evaluation and multicenter study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin. Blood Coagul Fibrinolysis 2014;25(8):860–870. doi:10.1097/MBC.0000000000000169.
   PubMed Web of Science ®Google Scholar
• Wartiovaara-Kautto U, Joutsi-Korhonen L, Ilveskero S, Armstrong E, Lassila R. Platelets significantly modify procoagulant activities in haemophilia A. Haemophilia 2011;17(5):743–751. doi:10.1111/j.1365-2516.2011.02601.x.
   PubMed Web of Science ®Google Scholar
• Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smed E, Wagenvoord R, Lecompte T, Béguin S. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 2002;32:249–253. doi:10.1159/000073575.
   PubMed Web of Science ®Google Scholar
• Helin TA, Lemponen M, Hjemdahl P, Rönquist-Nii Y, Lassila R, Joutsi-Korhonen L. From laboratory to clinical practice: dabigatran effects on thrombin and coagulation in patient samples. Thromb Res 2015;136(1):154–160. doi:10.1016/j.thromres.2015.04.032.
   PubMed Web of Science ®Google Scholar
• Dargaud Y, Wolberg AS, Luddington R, Regnault V, Spronk H, Baglin T, Lecompte T, Ten Cate H, Negrier C. Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: an international multicentre study. Thromb Res 2012;130(6):929–934. doi:10.1016/j.thromres.2012.07.017.
   PubMed Web of Science ®Google Scholar
• Bloem E, Meems H, van den Biggelaar M, van der Zwaan C, Mertens K, Meijer AB. Mass spectrometry-assisted study reveals that lysine residues 1967 and 1968 have opposite contribution to stability of activated factor VIII. J Biol Chem 2012;287(8):5775–5783.
   PubMed Web of Science ®Google Scholar
• van den Brink EN, Turenhout EA, Bank CM, Fijnvandraat K, Peters M, Voorberg J. Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain. Blood 2000;96(2):540–545.
   PubMed Web of Science ®Google Scholar
• Pitkänen H, Jouppila A, Mowinckel MC, Lemponen M, Patiwael S, Sandset PM, Lassila, R., Brinkman, Herm Jan M. Enhanced thrombin generation and reduced intact protein S in processed solvent detergent plasma. Thromb Res 2015;135(1):167–174. doi:10.1016/j.thromres.2014.10.020.
   PubMed Web of Science ®Google Scholar
• Chitlur M, Rivard GE, Lillicrap D, Mann K, Shima M, Young G. Recommendations for performing thromboelastography/thromboelastometry in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost 2014;12(1):103–106. doi:10.1111/jth.12513.
   PubMed Web of Science ®Google Scholar
• Brinkman HJ, Mertens K, van Mourik JA. Proteolytic cleavage of protein S during the hemostatic response. J Thromb Haemost 2005;3(12):2712–2720. doi:10.1111/j.1538-7836.2005.01647.x.
   PubMed Web of Science ®Google Scholar
• Gilbert GE, Novakovic VA, Shi J, Rasmussen J, Pipe SW. Platelet binding sites for factor VIII in relation to fibrin and phosphatidyl serine. Blood 2015;126(10):1237–1244. doi:10.1182/blood-2015-01-620245.
   PubMed Web of Science ®Google Scholar
• Dargaud Y, Luddington R, Baglin TP. Elimination of contact factor activation improves measurement of platelet-dependent thrombin generation by calibrated automated thrombography at low-concentration tissue factor. J Thromb Haemost 2006;4(5):1160–1161. doi:10.1111/j.1538-7836.2006.02117.x.
   PubMed Web of Science ®Google Scholar
• Bowman ML, Pluthero FG, Tuttle A, Casey L, Li L, Christensen H, Robinson KS, Lillicrap D, Kahr WHA, James P. Discrepant platelet and plasma von Willebrand factor (VWF) in von Willebrand disease (VWD) patients with p.Pro2808Leufs*24: discrepant platelet and plasma VWF. J Thromb Haemost 2017:1403–1411. doi:10.1111/jth.13722.
   PubMed Web of Science ®Google Scholar
• Schmidt DE, Majeed A, Bruzelius M, Odeberg J, Holmström M, Ågren A. A prospective diagnostic accuracy study evaluating rotational thromboelastometry and thromboelastography in 100 patients with von Willebrand disease. Haemophilia 2017;23(2):309–318. doi:10.1111/hae.13121.
   PubMed Web of Science ®Google Scholar
• Durila M. Nonactivated thromboelastometry able to detect fibrinolysis in contrast to activated methods (EXTEM, INTEM) in a bleeding patient. Blood Coag Fibrinolysis 2016;27(7):828–830. doi:10.1097/MBC.0000000000000479.
   PubMed Web of Science ®Google Scholar
• Szántó T, Joutsi-Korhonen L, Deckmyn H, Lassila R. New insights into von Willebrand disease and platelet function. Semin Thromb Hemost 2012;38(1):55–63. doi:10.1055/s-0031-1300952.
   PubMed Web of Science ®Google Scholar